Clinical Trials
157 trialsComparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Eastern Cooperative Oncology Group
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
H. Lee Moffitt Cancer Center and Research Institute
Multicentric Database for KRAS Mutant Pancreatic Cancer
Fudan University
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
National Institutes of Health Clinical Center (CC)
LEARN
University of Sydney
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
Imperial College London
VAPOR
Imperial College London
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
Pancreatic Cancer Genetics
Columbia University
iCaRe2
University of Nebraska
EXCEED
AstraZeneca
PREDICT-PANC
Medical College of Wisconsin
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers
University of Missouri-Columbia
DP-04
AstraZeneca
A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data
Shanghai Zhongshan Hospital
BASECAMP-1
A2 Biotherapeutics Inc.
Map HPB
University of Nottingham
PATAKESS
Centre Leon Berard
Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
SJFAMILY
St. Jude Children's Research Hospital
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
Mayo Clinic
PRECEDE
Arbor Research Collaborative for Health
CONVERCAP
Institut Bergonié
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
Nuvance Health
PANDOME
Nuvance Health
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
Nuvance Health
Collection of Circulating Biomarkers in Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
Columbia University
RAFPAN2
GCS Ramsay Santé pour l'Enseignement et la Recherche
(CLOCS-2)
Imperial College London
Evaluation of Resection Techniques for Pancreatic Tumors
Methodist Health System
TEM-PAC
Hull University Teaching Hospitals NHS Trust
ORI-EGI-03
Origin Sciences
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Mayo Clinic
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Mayo Clinic
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients
Vanderbilt University Medical Center
MR Guidance for Liver and Pancreas
University Health Network, Toronto
MOMENTUM
UMC Utrecht
OU-SCC-ctDNA
University of Oklahoma
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
M.D. Anderson Cancer Center
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
Johns Hopkins University
AI-Powered Precision Decision-Making for Pancreatic Diseases
Changhai Hospital
Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
Shengjing Hospital
MREDPCM
Shengjing Hospital
Pancreas Registry and High Risk Registry
Icahn School of Medicine at Mount Sinai
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Endocrine-exocrine Functions and Prognosis After Pancreatectomy
National Taiwan University Hospital
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
Abramson Cancer Center at Penn Medicine
Delayed Gastric Emptying After Pancreatic Surgery
National Taiwan University Hospital
A First-in-Human Study of FID-022 in Solid Tumor Patients
H. Lee Moffitt Cancer Center and Research Institute